Analytical performance of microparticle enzyme immunoassay and HPLC- tandem mass spectrometry in the determination of sirolimus in whole blood

Clinical Chemistry

Volumn 45, Issue 12, 1999, Pages 2278-2280

  Salm, Paul ^a   Taylor, Paul J ^a   Pillans, Peter I ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; RAPAMYCIN;

ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; MICROPARTICLE ENZYME IMMUNOASSAY;

EID: 0032757545     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.12.2278     Document Type: Article

References (16)

1. 1. Sehgal SN, Baker H, Verina C. Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterisation. J Antibiot 1975; 28:727-32.
2. 2. Morris RE. Rapamycins: antifungal, antitumour, antiproliferative and immunosuppressive macrolides. Transplant Rev 1992;6:39-87.
3. 3. Kahan BD, Napoli KL. Role of therapeutic drug monitoring of rapamycin. Transplant Proc 1998:30:2189-91.
4. 4. Taylor PJ, Johnson AG. Quantitative analysis of sirolimus (rapamycin) in blood by high performance liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr 1998;718:251-7.
5. 5. Streit F, Christians U, Schiebel HM, Napoli KL, Ernst L, Linck A. et al. Sensitive and specific quantification of sirolimus (rapamycin) and its metabolites in blood of kidney graft recipients by HPLC/electrospray-mass spectrometry. Clin Chem 1996:42:1417-25.
6. 6. Yatscoff RW, Faraci C, Bolingbroke P. Measurement of rapamycin in whole blood using reverse phase high-performance liquid chromatography. Ther DrugMonit 1992:14:138-41.
7. 7. Napoli KL, Kahan BD. Sample clean-up and high performance liquid chromatographic techniques for measurement of whole blood rapamycin concentrations. J Chromatogr B 1994:654:111-20.
8. 8. Napoli KL, Kahan BD. Routine clinical monitoring of sirolimus (rapamycin) whole blood concentrations by HPLC with ultraviolet detection. Clin Chem 1996:42:1943-8.
9. 9. Svensson JO, Brattström C, Säwe J. Determination of rapamycin in whole blood by HPLC. Ther Drug Monit 1997;19:112-6.
10. 10. Blonski DR, Brate E, Bergmann M, Luczkiw J, McMahon K, Matuszewski K, et al. Clinical studies on IMx® sirolimus, a semi-automated whole blood assay [Abstract]. Clin Chem 1998;44:A92.
11. 11. Shah VP, Midha KK. Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies. J Pharm Sci 1992:81:309-12.
12. 12. Holt DW, Jones K, Johnston A, Horwatt R, Hicks D. An immunoassay for the measurement of sirolimus [Abstract]. Clin Chem 1998;44:A94.
13. 13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
14. 14. Kahan BD, Podbielski J, Napoli KL, Katz SM, Meier Kriesche H-U, Van Buren CT. Immunosuppressive effects and safety of a sirolimus/cyclosporin combination regimen for renal transplantation. Transplantation 1998:66: 1040-6.
15. 15. Taylor PJ, Salm P, Norris RLG, Ravenscroft PJ, Pond SM. Comparison of high-performance liquid chromatography and monoclonal fluorescence polarisation immunoassay for the determination of whole blood cyclosporin A in liver and heart transplant patients. Ther Drug Monit 1994:16:526-30.
16. 16. Cogill JL, Taylor PJ, Westley IS, Morris RG, Lynch SV, Johnson AG. Evaluation of the tacrolimus II microparticle enzyme immunoassay (MEIA II) in liver and renal transplant recipients. Clin Chem 1998:44:1942-6.